From Gov. DeWine Comms <[email protected]>
Subject Statement from Governor DeWine on Hydroxychloroquine
Date July 30, 2020 1:29 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Governor DeWine COVID-19 Banner [ [link removed] ]
*FOR IMMEDIATE RELEASE:*
July 30, 2020 *MEDIA CONTACTS:*
Dan Tierney: 614-644-0957
Breann Almos: 614-644-0957





(COLUMBUS, Ohio)Ohio Governor Mike DeWine issued the following statement regarding the new rule issued by the Ohio Board of Pharmacy regarding the use of hydroxychloroquine to treat COVID-19:

I agree with the statement from Dr. Steven Hahn, Commissioner of the Food and Drug Administration, that the decision about prescribing hydroxychloroquine to treat COVID-19 should be between a doctor and a patient. Therefore, I am asking the Ohio Board of Pharmacy to halt their new rule prohibiting the selling or dispensing of hydroxychloroquine or chloroquine for the treatment or prevention of COVID-19. The Board of Pharmacy and the State Medical Board of Ohio should revisit the issue, listen to the best medical science, and open the process up for comment and testimony from experts.


30


________________________________________________________________________

STAY CONNECTED: Visit us on Facebook [ [link removed] ] Visit us on Twitter [ [link removed] ] Visit us on YouTube [ [link removed] ] Visit us on Instagram [ [link removed] ]

SUBSCRIBER SERVICES:
Governor.Ohio.gov [ [link removed] ] | Unsubscribe [ [link removed] ]|Help [ [link removed] ]

________________________________________________________________________

This email was sent to [email protected] using GovDelivery Communications Cloud on behalf of: Opportunities for Ohioans with Disabilities 150 E. Campus View Blvd Columbus, Ohio 43235 GovDelivery logo [ [link removed] ]
Screenshot of the email generated on import

Message Analysis